IGFBP7 and acute kidney injury: Among functional biomarkers, cell cycle arrest biomarkers TIMP-2 and IGFBP7 have gained attention based on two large clinical trials demonstrating that a combined panel of these biomarkers could predict imminent AKI (within 12 hours) in critically ill patients [29].